Timber Hill’s Pfizer PFE Stock Holding History

Timber Hill’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-67,076	Closed	-$2.81M	–	50
2018 Q3	$2.81M	Buy	+67,076	New	+$2.58M	2.83%	7
2018 Q2	–	Sell	-155,852	Closed	-$5.25M	–	218
2018 Q1	$5.25M	Sell	155,852 -17,431	-10%	-$599K	0.8%	22
2017 Q4	$5.96M	Buy	173,283 +138,019	+391%	+$4.71M	0.38%	39
2017 Q3	$1.19M	Buy	+35,264	New	+$1.13M	0.11%	166
2017 Q1	–	Sell	-73,878	Closed	-$2.33M	–	2334
2016 Q4	$2.28M	Buy	+73,878	New	+$2.26M	0.01%	840
2015 Q3	–	Sell	-251,593	Closed	-$8.07M	–	2570
2015 Q2	$8M	Buy	+251,593	New	+$8.2M	0.04%	414
2014 Q4	–	Sell	-285,912	Closed	-$8.2M	–	2675
2014 Q3	$8.02M	Buy	285,912 +221,807	+346%	+$6.23M	0.03%	423
2014 Q2	$1.8M	Buy	64,105 +49,251	+332%	+$1.4M	0.01%	1242
2014 Q1	$453K	Sell	14,854 -73,368	-83%	-$2.19M	﹤0.01%	2102
2013 Q4	$2.56M	Buy	+88,222	New	+$2.57M	0.01%	1190

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Timber Hill's PFE Position: Q4 2018 in Review

Timber Hill sold out of Pfizer (PFE) in Q4 2018, closing a stake of 67,076 shares — an estimated $2.81M sold.

Timber Hill first reported a position in PFE in Q4 2013 and held it in 10 quarters. The position peaked at $8.02M in Q3 2014. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Timber Hill reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
Timber Hill sold 67,076 Pfizer shares in Q4 2018, an estimated $2.81M.
Timber Hill first reported a position in Pfizer in Q4 2013 and held it in 10 quarters.
Timber Hill's Pfizer position peaked at $8.02M in Q3 2014.
2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Timber Hill's 13F filing for Q4 2018, filed 11 Feb 2019.